Search
Search Results
##search.searchResults.foundPlural##
-
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1357PDF: 603HTML: 1731Figures: 230Fifures Sanz: 236tables Sanz: 246Untitled: 230 -
Interstitial pneumonia triggered by H1N1 influenza A virus as the initial presentation of chronic myeloid leukemia
992PDF: 589HTML: 264Suppl. Files: 371 -
TIMING FOR STEP-DOWN THERAPY OF CANDIDEMIA IN NON-NEUTROPENIC PATIENTS: AN INTERNATIONAL MULTI-CENTER STUDY Stepdown Therapy of Candidemia
2504PDF: 824HTML: 391 -
WHAT ARE FUNGAL INFECTIONS?
4488PDF: 2572HTML: 27724de Pauw: 318 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4889PDF: 4004HTML: 385 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
2383PDF: 933HTML: 278 -
The diagnostic pitfalls of mucormycosis
1111PDF: 797HTML: 315 -
A 9month-old-boy with atypical hemophagocytic lymphohistiocytosis
2273PDF: 902HTML: 1251 -
RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM
1479PDF: 1179HTML: 285 -
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN ADULTS: LOW INCIDENCE OF PRIMARY NEOPLASM AS A TRIGGER IN A CASE SERIES FROM TURKEY
1756PDF: 1042HTML: 276Figure 1: 229 -
T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections
2008PDF: 834HTML: 605 -
The diagnostic sensitivity of beta-D-glucan assay in patients with chronic disseminated candidiasis
1441PDF: 1213PDF: 984HTML: 277 -
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
13099PDF: 1803HTML: 4386Cover letter: 320Figure 1: 342 -
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
957PDF: 542HTML: 1334 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4282PDF: 1267HTML: 2140Fig.1: 262Fig. 2: 152Table 1: 269Table2: 297Table 3: 288 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2698PDF: 897HTML: 1770 -
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
1279PDF: 1273Suppl. Files: 615HTML: 117 -
CANDIDA ASSOCIATED BLOODSTREAM INFECTIONS IN PEDIATRIC HEMATOLOGY PATIENTS: SINGLE CENTER EXPERIENCE
4618PDF: 1021HTML: 1379Table1: 326 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
2177PDF: 884HTML: 740Table1: patient's characteristics: 277Table 2: profile of each patient: 263 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1624PDF: 1438HTML: 126 -
Anemia in the elderly: not always what it seems.
3482PDF: 1201HTML: 1831Figure 1: 278Figure 1 revised: 322 -
IS IT POSSIBLE TO PREDICT TUMOR PROGRESSION THROUGH GENOMIC CHARACTERIZATION OF MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA? MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA
2754PDF: 1281HTML: 181 -
-
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
2132PDF: 1162HTML: 292 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
5067PDF: 1940HTML: 2912Untitled: 361 -
Common parasite with uncommon associations
1632PDF: 778HTML: 1879 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1731PDF: 1121HTML: 161







